Overexpression of NDRG2 Can Inhibit Neuroblastoma Cell Proliferation through Negative Regulation by CYR61 |
Zhang, Zhi-Guo
(Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital)
Li, Gang (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) Feng, Da-Yun (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) Zhang, Jian (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University) Zhang, Jing (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University) Qin, Huai-Zhou (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) Ma, Lian-Ting (Postdoctoral Research Station of Neurosurgery, Wuhan General Hospital of Guangzhou Command, PLA) Gao, Guo-Dong (Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital) Wu, Lin (Department of Biochemistry and Molecular Biology, State Key Laboratory of Cancer Biology, the Fourth Military Medical University) |
1 | Xie D, Yin D, Wang HJ, et al (2004). Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res, 10, 2072-81. DOI ScienceOn |
2 | Zhao H, Zhang J, Lu J, et al (2008). Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer. BMC Cancer, 8, 303-11. DOI ScienceOn |
3 | Tong X, Xie D, O'Kelly J, et al (2001). Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem, 276, 47709-14. DOI ScienceOn |
4 | Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R (2002). Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene, 21, 8178-85. DOI ScienceOn |
5 | Tschan MP, Shan D, Laedrach J, et al (2010). NDRG1/2 expression is inhibited in primary acute myeloid leukemia. Leuk Res, 34, 393-8 DOI ScienceOn |
6 | Xie D, Yin D, Tong X, et al (2004). Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res, 64, 1987-96. DOI ScienceOn |
7 | Yang J, Li Y, Wu L, et al (2010). NDRG2 in rat liver regeneration: role in proliferation and apoptosis. Wound Repair Regen, 18, 524-31. DOI ScienceOn |
8 | Yang J, Zheng J, Wu L, et al (2011). NDRG2 ameliorates hepatic fibrosis by inhibiting the TGF-beta1/Smad pathway and altering the MMP2/TIMP2 ratio in rats. PLoS One, 6, e27710. DOI |
9 | Yao L, Zhang J, Liu X (2008). NDRG2: a Myc-repressed gene involved in cancer and cell stress. Acta Biochim Biophys Sin, 40, 625-35. DOI ScienceOn |
10 | Yu Y, Gao Y, Wang H, et al (2008). The matrix protein CCN1 (CYR61). promotes proliferation, migration and tube formation of endothelial progenitor cells. Exp Cell Res, 314, 3198-208. DOI ScienceOn |
11 | Ma J, Jin H, Wang H, et al (2008). Expression of NDRG2 in clear cell renal cell carcinoma. Biol Pharm Bull, 31, 1316-20. DOI ScienceOn |
12 | Lorentzen A, Lewinsky RH, Bornholdt J, Vogel LK, Mitchelmore C (2011). Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2). in human cancers with focus on breast cancer. BMC Cancer, 11, 14-21. DOI ScienceOn |
13 | Lorentzen A, Vogel LK, Lewinsky RH, et al (2007). Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma. BMC Cancer, 7, 192-9. DOI |
14 | Lusis EA, Watson MA, Chicoine MR, et al (2005). Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res, 65, 7121-6. DOI ScienceOn |
15 | Matthay KK (1995). Neuroblastoma: a clinical challenge and biologic puzzle. CA Cancer J Clin, 45, 179-92. DOI ScienceOn |
16 | Salic A, Mitchison TJ (2008). A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA, 105, 2415-20. DOI ScienceOn |
17 | Kim A, Kim MJ, Yang Y, et al (2009). Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells. Carcinogenesis, 30, 927-36. DOI ScienceOn |
18 | Shi H, Jin H, Chu D, et al (2009). Suppression of N-myc downstream-regulated gene 2 is associated with induction of Myc in colorectal cancer and correlates closely with differentiation. Biol Pharm Bull, 32, 968-75. DOI ScienceOn |
19 | Shi H, Li N, Li S, et al (2010). Expression of NDRG2 in esophageal squamous cell carcinoma. Cancer Sci, 101, 1292-9. DOI ScienceOn |
20 | Tong X, O'Kelly J, Xie D, et al (2004). Cyr61 suppresses the growth of non-small-cell lung cancer cells via the betacatenin-c-myc-p53 pathway. Oncogene, 23, 4847-55. DOI ScienceOn |
21 | Foletta VC, Prior MJ, Stupka N, et al (2009). NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors. J Physiol, 587, 1619-34. DOI ScienceOn |
22 | Jandova J, Beyer TE, Meuillet EJ, Watts GS (2012). The matrix protein CCN1/CYR61 is required for alpha(V). beta(5). -mediated cancer cell migration. Cell Biochem Funct, 30, 687-95 DOI ScienceOn |
23 | Kang K, Jung H, Nam S, Lim JS (2011). NDRG2 Promotes GATA-1 Expression through Regulation of the JAK2/STAT Pathway in PMA-stimulated U937 Cells. Immune Netw, 11, 348-57. DOI ScienceOn |
24 | Kim JT, Kim JW, Kang YH, et al (2012). NDRG2 and PRA1 interact and synergistically inhibit T-cell factor/beta-catenin signaling. FEBS Lett, 586, 3962-8. DOI ScienceOn |
25 | Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 expression decreases with tumor stages and regulates TCF/beta-catenin signaling in human colon carcinoma. Carcinogenesis, 30, 598-605. DOI ScienceOn |
26 | Chien W, Kumagai T, Miller CW, et al (2004). Cyr61 suppresses growth of human endometrial cancer cells. J Biol Chem, 279, 53087-96. DOI ScienceOn |
27 | Lee DC, Kang YK, Kim WH, et al (2008). Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis. Cancer Res, 68, 4210-20. DOI ScienceOn |
28 | Lee KB, Byun HJ, Park SH, et al (2012). CYR61 controls p53 and NF-kappaB expression through PI3K/Akt/mTOR pathways in carboplatin-induced ovarian cancer cells. Cancer Lett, 315, 86-95. DOI ScienceOn |
29 | Li ZQ, Ding W, Sun SJ, et al (2012). Cyr61/CCN1 is regulated by Wnt/beta-catenin signaling and plays an important role in the progression of hepatocellular carcinoma. PLoS One, 7, e35754. DOI |
30 | Choi SC, Yoon SR, Park YP, et al (2007). Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death. Exp Mol Med, 39, 705-14. DOI ScienceOn |
31 | Deng Y, Yao L, Chau L, et al (2003). N-Myc downstreamregulated gene 2 (NDRG2). inhibits glioblastoma cell proliferation. Int J Cancer, 106, 342-7. DOI ScienceOn |
32 | Kim YJ, Yoon SY, Kim JT, et al (2009). NDRG2 suppresses cell proliferation through down-regulation of AP-1 activity in human colon carcinoma cells. Int J Cancer, 124, 7-15. DOI ScienceOn |
33 | Xu C, Zheng J, Zhang H, et al (2012). MSP58 knockdown inhibits the proliferation of esophageal squamous cell carcinoma in vitro and in vivo. Asian Pac J Cancer Prev, 13, 3233-8 과학기술학회마을 DOI ScienceOn |
34 | Sabile AA, Arlt MJ, Muff R, et al (2012). Cyr61 expression in Osteosarcoma indicates poor prognosis and promotes intratibial growth and lung metastasis in mice. J Bone Miner Res, 27, 58-67 DOI ScienceOn |
![]() |